94 related articles for article (PubMed ID: 7778267)
1. Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool.
Allen P; Worland S; Gold L
Virology; 1995 Jun; 209(2):327-36. PubMed ID: 7778267
[TBL] [Abstract][Full Text] [Related]
2. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Arch Biochem Biophys; 1993 Feb; 300(2):756-60. PubMed ID: 8434953
[TBL] [Abstract][Full Text] [Related]
3. Analysis of human immunodeficiency virus type 1 integrase mutants.
Ansari-Lari MA; Donehower LA; Gibbs RA
Virology; 1995 Aug; 211(1):332-5. PubMed ID: 7544046
[TBL] [Abstract][Full Text] [Related]
4. Direct mass spectrometric determination of the stoichiometry and binding affinity of the complexes between nucleocapsid protein and RNA stem-loop hairpins of the HIV-1 Psi-recognition element.
Hagan N; Fabris D
Biochemistry; 2003 Sep; 42(36):10736-45. PubMed ID: 12962498
[TBL] [Abstract][Full Text] [Related]
5. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R
J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319
[TBL] [Abstract][Full Text] [Related]
6. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Biochem Biophys Res Commun; 1993 May; 192(3):1409-14. PubMed ID: 8389550
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of human immunodeficiency virus type 1 reverse transcriptase primer tRNA binding by fluorescence spectroscopy: specificity and comparison to primer/template binding.
Thrall SH; Reinstein J; Wöhrl BM; Goody RS
Biochemistry; 1996 Apr; 35(14):4609-18. PubMed ID: 8605212
[TBL] [Abstract][Full Text] [Related]
8. Stem-loop SL4 of the HIV-1 psi RNA packaging signal exhibits weak affinity for the nucleocapsid protein. structural studies and implications for genome recognition.
Amarasinghe GK; Zhou J; Miskimon M; Chancellor KJ; McDonald JA; Matthews AG; Miller RR; Rouse MD; Summers MF
J Mol Biol; 2001 Dec; 314(5):961-70. PubMed ID: 11743714
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal region of HIV-1 integrase is required for integration activity, but not for DNA-binding.
Schauer M; Billich A
Biochem Biophys Res Commun; 1992 Jun; 185(3):874-80. PubMed ID: 1627142
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 integrase stabilizes a linearized HIV-1 LTR plasmid in vivo.
Faust EA; Acel A; Udashkin B; Wainberg MA
Biochem Mol Biol Int; 1995 Jul; 36(4):745-58. PubMed ID: 8528137
[TBL] [Abstract][Full Text] [Related]
12. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
Luedtke NW; Liu Q; Tor Y
Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
[TBL] [Abstract][Full Text] [Related]
13. The major HIV-1 packaging signal is an extended bulged stem loop whose structure is altered on interaction with the Gag polyprotein.
Zeffman A; Hassard S; Varani G; Lever A
J Mol Biol; 2000 Apr; 297(4):877-93. PubMed ID: 10736224
[TBL] [Abstract][Full Text] [Related]
14. Identification of a high affinity nucleocapsid protein binding element within the Moloney murine leukemia virus Psi-RNA packaging signal: implications for genome recognition.
D'Souza V; Melamed J; Habib D; Pullen K; Wallace K; Summers MF
J Mol Biol; 2001 Nov; 314(2):217-32. PubMed ID: 11718556
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human immunodeficiency virus type 1 integrase mutants.
Ansari-Lari MA; Donehower LA; Gibbs RA
Virology; 1995 Nov; 213(2):680. PubMed ID: 7491794
[No Abstract] [Full Text] [Related]
16. In vitro biochemical activities associated with recombinant HIV-1 integrase.
Pemberton IK; Singh OM
Biochem Soc Trans; 1993 Feb; 21(1):51S. PubMed ID: 8449335
[No Abstract] [Full Text] [Related]
17. A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradation.
Fan N; Rank KB; Slade DE; Poppe SM; Evans DB; Kopta LA; Olmsted RA; Thomas RC; Tarpley WG; Sharma SK
Biochemistry; 1996 Jul; 35(30):9737-45. PubMed ID: 8703945
[TBL] [Abstract][Full Text] [Related]
18. Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: in vitro activities and incorporation of a fusion protein into viral particles.
Katz RA; Merkel G; Skalka AM
Virology; 1996 Mar; 217(1):178-90. PubMed ID: 8599202
[TBL] [Abstract][Full Text] [Related]
19. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
[TBL] [Abstract][Full Text] [Related]
20. A specific RNA structural motif mediates high affinity binding by the HIV-1 nucleocapsid protein (NCp7).
Allen P; Collins B; Brown D; Hostomsky Z; Gold L
Virology; 1996 Nov; 225(2):306-15. PubMed ID: 8918917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
